|
|
(+)-Camphor + reduced_putidaredoxin + O2 + H+ <=> (+)-exo-5-hydroxycamphor + A + H2O
|
1.14.15.1
camphor 5-monooxygenase
|
–
|
|
BRENDA:
BR33651
KEGG:
R03818
MetaCyc:
R541-RXN
|
|
|
|
(+)-bornane-2,5-dione + FMNH2 + O2 <=> (+)-5-oxo-1,2-campholide + FMN + H2O + H+
|
1.14.14.108
2,5-diketocamphane 1,2-monooxygenase
1.14.14.155
3,6-diketocamphane 1,2-monooxygenase
|
–
–
|
|
BRENDA:
BR40408;
BR52467;
BS363697
KEGG:
R04102;
R12149
MetaCyc:
R543-RXN;
RXN-13043
|
|
|
|
(+)-bornane-2,5-dione + FMNH2 + O2 <=> (+)-5-oxo-1,2-campholide + FMN + H2O + H+
|
1.14.14.108
2,5-diketocamphane 1,2-monooxygenase
1.14.14.155
3,6-diketocamphane 1,2-monooxygenase
|
–
–
|
|
BRENDA:
BR40408;
BR52467;
BS363697
KEGG:
R04102;
R12149
MetaCyc:
R543-RXN;
RXN-13043
|
|
|
|
H+ + [(1R)-2,2,3-trimethyl-5-oxocyclopent-3-enyl]acetyl-CoA + NADPH + O2 <=> [(2R)-3,3,4-trimethyl-6-oxo-3,6-dihydro-1H-pyran-2-yl]acetyl-CoA + NADP+ + H2O
|
1.14.13.160
(2,2,3-trimethyl-5-oxocyclopent-3-enyl)acetyl-CoA 1,5-monooxygenase
|
–
|
|
BRENDA:
BR50108
KEGG:
R10044
MetaCyc:
R546-RXN
|
|
|
|
[(1R)-4,5,5-trimethyl-2-oxocyclopent-3-enyl]acetate + ATP + CoA <=> [(1R)-2,2,3-trimethyl-5-oxocyclopent-3-enyl]acetyl-CoA + AMP + diphosphate
|
6.2.1.38
(2,2,3-trimethyl-5-oxocyclopent-3-enyl)acetyl-CoA synthase
|
–
|
|
BRENDA:
BR50130
KEGG:
R10003
MetaCyc:
R545-RXN
|
|
|
|
(+)-5-oxo-1,2-campholide <=> H+ + [(1R)-4,5,5-trimethyl-2-oxocyclopent-3-enyl]acetate
|
0.0.0.0
|
–
|
|
BRENDA:
BR53095
KEGG:
R10022
MetaCyc:
R544-RXN;
RXN-13044
|
|
|
|
[(2R)-3,3,4-trimethyl-6-oxo-3,6-dihydro-1H-pyran-2-yl]acetyl-CoA <=> H+ + DELTA2,5-3,4,4-trimethylpimeloyl-CoA
|
0.0.0.0
|
–
|
|
BRENDA:
BR53096
MetaCyc:
R547-RXN
|
|
|
|
(+)-exo-5-hydroxycamphor + NAD+ <=> H+ + (+)-bornane-2,5-dione + NADH
|
1.1.1.327
5-exo-hydroxycamphor dehydrogenase
|
–
|
|
BRENDA:
BR50091
KEGG:
R10021
MetaCyc:
R542-RXN
|
|